Apolipoprotein A5 polymorphism and triglycerides in ischemic cerebrovascular disease

Hong Mei Wen, Ka Sing Wong, Ho Keung Ng, Wing Sze Cheung, Ru Xun Huang, Brian Tomlinson, G. Neil Thomas, Larry Baum*

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapter


    Serum lipids are correlated with certain types of cerebrovascular atherosclerosis. The -1131T>C polymorphism in apolipoprotein A5 (APOA5) is associated with triglyceride levels. We investigated associations among this polymorphism, triglycerides, and stroke in 160 cases of acute ischemic stroke or transient ischemic attack and 157 healthy control subjects. Both patients and controls were Chinese. The APOA5 polymorphism was significantly associated with triglyceride levels both in patients and controls. The average triglyceride level was 70% greater in patients and 92% greater in controls with CC than with TT genotypes. Logistic regression indicated that triglyceride level was an independent risk factor for ischemic stroke in this population. However, APOA5 genotypes were not significantly associated with strokes or stroke subtypes, though larger studies would be needed to exclude the possibility of a small effect on stroke risk.

    Original languageEnglish
    Title of host publicationBiochemistry and Molecular Biology: The Complexity of Human Traits and Diseases
    PublisherNova Science Publishers, Inc.
    Number of pages10
    ISBN (Print)9781634823135, 9781634823128
    Publication statusPublished - 1 Apr 2015

    ASJC Scopus subject areas

    • General Biochemistry,Genetics and Molecular Biology


    Dive into the research topics of 'Apolipoprotein A5 polymorphism and triglycerides in ischemic cerebrovascular disease'. Together they form a unique fingerprint.

    Cite this